IBDEI12E ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19070,2)
 ;;=^274399
 ;;^UTILITY(U,$J,358.3,19071,0)
 ;;=838.09^^125^1221^27
 ;;^UTILITY(U,$J,358.3,19071,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19071,1,3,0)
 ;;=3^838.09
 ;;^UTILITY(U,$J,358.3,19071,1,5,0)
 ;;=5^Dislocation of foot, closed dislocation; other, toe(s)
 ;;^UTILITY(U,$J,358.3,19071,2)
 ;;=^274400
 ;;^UTILITY(U,$J,358.3,19072,0)
 ;;=12.5^1^125^1221^16^-DIABETES MELLITUS^1^1
 ;;^UTILITY(U,$J,358.3,19072,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19072,1,3,0)
 ;;=3
 ;;^UTILITY(U,$J,358.3,19072,1,5,0)
 ;;=5
 ;;^UTILITY(U,$J,358.3,19073,0)
 ;;=64.5^1^125^1221^19^-Dislocation^1^1
 ;;^UTILITY(U,$J,358.3,19073,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19073,1,3,0)
 ;;=3
 ;;^UTILITY(U,$J,358.3,19073,1,5,0)
 ;;=5
 ;;^UTILITY(U,$J,358.3,19074,0)
 ;;=459.10^^125^1221^28
 ;;^UTILITY(U,$J,358.3,19074,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19074,1,3,0)
 ;;=3^459.10
 ;;^UTILITY(U,$J,358.3,19074,1,5,0)
 ;;=5^Post Phlebotic Syndrome
 ;;^UTILITY(U,$J,358.3,19074,2)
 ;;=Post Phlebotic Syndrome^328597
 ;;^UTILITY(U,$J,358.3,19075,0)
 ;;=719.7^^125^1221^18
 ;;^UTILITY(U,$J,358.3,19075,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19075,1,3,0)
 ;;=3^719.7
 ;;^UTILITY(U,$J,358.3,19075,1,5,0)
 ;;=5^Difficulty In Walking
 ;;^UTILITY(U,$J,358.3,19075,2)
 ;;=^329945
 ;;^UTILITY(U,$J,358.3,19076,0)
 ;;=453.40^^125^1221^5
 ;;^UTILITY(U,$J,358.3,19076,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19076,1,3,0)
 ;;=3^453.40
 ;;^UTILITY(U,$J,358.3,19076,1,5,0)
 ;;=5^Deep vein thrombosis lower extremity
 ;;^UTILITY(U,$J,358.3,19076,2)
 ;;=^338554
 ;;^UTILITY(U,$J,358.3,19077,0)
 ;;=357.2^^125^1221^17
 ;;^UTILITY(U,$J,358.3,19077,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19077,1,3,0)
 ;;=3^357.2
 ;;^UTILITY(U,$J,358.3,19077,1,5,0)
 ;;=5^Diabetic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,19077,2)
 ;;=^96321
 ;;^UTILITY(U,$J,358.3,19078,0)
 ;;=692.9^^125^1222^1
 ;;^UTILITY(U,$J,358.3,19078,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19078,1,3,0)
 ;;=3^692.9
 ;;^UTILITY(U,$J,358.3,19078,1,5,0)
 ;;=5^Eczema
 ;;^UTILITY(U,$J,358.3,19078,2)
 ;;=^27800
 ;;^UTILITY(U,$J,358.3,19079,0)
 ;;=691.8^^125^1222^2
 ;;^UTILITY(U,$J,358.3,19079,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19079,1,3,0)
 ;;=3^691.8
 ;;^UTILITY(U,$J,358.3,19079,1,5,0)
 ;;=5^Eczema, allergic
 ;;^UTILITY(U,$J,358.3,19079,2)
 ;;=^87342
 ;;^UTILITY(U,$J,358.3,19080,0)
 ;;=782.3^^125^1222^3
 ;;^UTILITY(U,$J,358.3,19080,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19080,1,3,0)
 ;;=3^782.3
 ;;^UTILITY(U,$J,358.3,19080,1,5,0)
 ;;=5^Edema (any site)
 ;;^UTILITY(U,$J,358.3,19080,2)
 ;;=^38340
 ;;^UTILITY(U,$J,358.3,19081,0)
 ;;=726.70^^125^1222^4
 ;;^UTILITY(U,$J,358.3,19081,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19081,1,3,0)
 ;;=3^726.70
 ;;^UTILITY(U,$J,358.3,19081,1,5,0)
 ;;=5^Enthesopathy of ankle & tarsus, unspecified
 ;;^UTILITY(U,$J,358.3,19081,2)
 ;;=^272548
 ;;^UTILITY(U,$J,358.3,19082,0)
 ;;=736.72^^125^1222^5
 ;;^UTILITY(U,$J,358.3,19082,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19082,1,3,0)
 ;;=3^736.72
 ;;^UTILITY(U,$J,358.3,19082,1,5,0)
 ;;=5^Equinus deformity of foot, acquired
 ;;^UTILITY(U,$J,358.3,19082,2)
 ;;=^272744
 ;;^UTILITY(U,$J,358.3,19083,0)
 ;;=726.91^^125^1222^6
 ;;^UTILITY(U,$J,358.3,19083,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19083,1,3,0)
 ;;=3^726.91
 ;;^UTILITY(U,$J,358.3,19083,1,5,0)
 ;;=5^Exostosis of unspecified site
 ;;^UTILITY(U,$J,358.3,19083,2)
 ;;=^43688
 ;;^UTILITY(U,$J,358.3,19084,0)
 ;;=728.71^^125^1223^1
 ;;^UTILITY(U,$J,358.3,19084,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19084,1,3,0)
 ;;=3^728.71
